NCT00097591 - A Comparison of Prasugrel (CS-747) and Clopidogrel in Acute Coronary Syndrome Subjects Who Are to Undergo Percutaneous Coronary Intervention | Biotech Hunter

Enrollment

13,619

Participants

Timeline

Start Date

November 30, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

Coronary ArteriosclerosisAcute Coronary Syndromes

Interventions

DRUG

Prasugrel

Administered orally

DRUG

Clopidogrel

Administered orally

Trial Locations (1)

Unknown

For more information regarding investigative sites for this trial, call 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri 9 AM - 5 PM Eastern Time (UTC/GMT - 5 hours, EST), Global Quintiles Study Line (1-866-615-4672) or speak with your physician, Indianapolis